PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsImmune system diseases
MeSH D007154 - immune system diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D007154: 
Immune system diseases
2 Companies
2 Drugs
$
Success rate
D000090362:Mast cell activation disorders
0 Companies
0 Drugs
Success rate
D001327:Autoimmune diseases
1 Company
1 Drug
$
Success rate
D004899:Fetal erythroblastosis
0 Companies
0 Drugs
Success rate
D006086:Graft vs host disease
100 Companies
11 Drugs
$
Success rate
D006967:Hypersensitivity
0 Companies
0 Drugs
Success rate
D007153:Immunologic deficiency syndromes
4 Companies
1 Drug
$
Success rate
D007160:Immunoproliferative disorders
1 Company
1 Drug
$
Success rate
D011696:Thrombocytopenic purpura
1 Company
1 Drug
$
Success rate
D015432:Membranoproliferative glomerulonephritis
0 Companies
0 Drugs
Success rate
D054019:Immune reconstitution inflammatory syndrome
0 Companies
0 Drugs
Success rate
D065227:Transfusion reaction
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
76%
22/29
Phase 2
13%
5/40
Phase 3
9%
1/11
Approved: 1Overall Success rate: 1%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Bristol Myers Squibb
Idecabtagene vicleucel
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use